Heparin Cofactor 2 Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals
スポンサーリンク
概要
著者
-
Azuma Hiroyuki
徳島大学 ヘルスバイオサイエンス研究部生体情報内科学
-
Takamori Nobuyuki
Division Of Cardiovascular Medicine Health Insurance Naruto Hospital
-
Azuma Hiroyuki
Department Of Medicine And Bioregulatory Sciences The University Of Tokushima Graduate School Of Hea
-
Kojima Akihiro
Department Of Medicine And Bioregulatory Sciences The University Of Tokushima Graduate School Of Hea
-
Takamori Nobuyuki
Divison Of Cardiology Health Insurance Naruto Hospital
関連論文
- FRS-026 HIF-1α in T cells pathway plays a crucial role in the progression of arteriosclerosis(Novel Mechanisms in Atherosclerosis (IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-211 HIF-ARNT Transcriptional System in T Cells Has a Pivotal Role in Vascular Inflammation and Remodeling(Atherosclerosis, basic-2 (H) OJ36,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-070 Exaggerated Atherosclerosis in Heparin Cofactor II-Deficient ApoE Knockout Mice(Atherosclerosis, basic-8, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-216 Acceleration of Angiotensin II-Induced Coronary Artery Remodeling in Androgen Receptor Knockout Male Mice(Atherosclerosis, basic-2 (H) OJ36,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Soci
- OE-127 Androgen-Androgen Receptor System Counteracts Doxorubicin-Induced Cardiotoxicity through Attenuating Oxidative Stress-Induced Mitochondrial Damage in Murine Male Heart(Heart failure, basic-1 (M) OE22,Oral Presentation (English),The 70th Anniversary
- Androgen Receptor Gene Knockout Male Mice Exhibit Exacerbated Cardiotoxicity and Increased Mortality by Doxorubicin Administration(Cardiac Function, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Arterial Cuff Injury Causes Enhanced Neointimal Formation and Increased Adventitial Area in Heterozygous Heparin Cofactor II Deficient Mice(Atherosclerosis, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-359 Impaired Cardiac Hypertrophic Response and Exacerbated Cardiac Fibrosis in Angiotensin Il-Loaded Male Mice Lacking Androgen Receptor(Molecular Biology, Myocardium 1 (M) : PJ60)(Poster Session (Japanese))
- OJ-373 Vitamin D/Vitamin D Receptor System Regulates Antithrombogenicity in vivo(Thromboembolism/Thrombolysis 3 (IHD) : OJ45)(Oral Presentation (Japanese))
- Heparin Cofactor II Is Inversely Related to the Severity of Carotid Atherosclerosis
- Elevated blood pressure with a cardiovascular remodeling in mice lacking vitamin D receptor
- Infective Endocarditis Caused by Lactobacillus
- PE-347 Early Detection of Myocardial Damage in Female Carriers of Duchenne Muscular Dystrophy : the Utility of Cardiac Magnetic Resonance(PE058,Cardiomyopathy/Hypertrophy (Clinical) 1 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The
- DPE-042 Plasma Aldosterone Concentration is Associated with Cognitive Impairement in Patients with Hypertension(DPE07,Hypertension, Clinical (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-366 Bosentan, an Endothelin Receptor Antagonist, Exerts Protective Actions against Systemic Sclerosis-related Peripheral Circulation Insufficiency(OE62,Peripheral Circulation/Vascular Disease (Therapy) (H),Oral Presentation (English),The 73rd Annual Sc
- OE-213 Pitavastatin Exerts LDL Cholesterol Reduction-independent Protective Action for Cardiac and Renal Function in Patients with Dyslipidemia(OE36,Atherosclerosis (Clinical/Treatment) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting
- Heparin Cofactor II is an Independent Protective Factor against Peripheral Arterial Disease in Elderly Subjects with Cardiovascular Risk Factors
- PE-209 Pitavastatin Excretes eNOS-independent Protective Action against Angiotensin II-induced Atrial Remodeling through Attenuating Rac1-madiated Oxidative Stress(PE035,Cardiovascular Pharmacology (Basic) (H),Poster Session (English),The 73rd Annual Scie
- PE-163 HMG-CoA Reductase Inhibitor Pitavastatin Increases the Expression of Endothelial NOS through Activation of ERK5-KLF2 Pathway in Vascular Endothelial Cells(Cardiovascular pharmacology, basic/clinical(03)(H),Poster Session(English),The 72nd Annual Sc
- OE-024 An eNOS-independent Protective Action of Pitavastatin against Angiotensin II-induced Cardiorenal Damage through Attenuating Rac-1-mediated Oxidative Stress(Cardiovascular pharmacology, basic/clinical(01)(H),Oral Presentation(English),The 72nd Annua
- PE-570 Therapeutic Angiogenesis by Transplantation of Atologous Peripheral-blood Mononuclear Cells Mobilized by Human Recombinant Erythropoietin in Patients with Severe Limb Ischemia(Regeneration (angiogenesis/myocardial regeneration)-4, The 71st Annual S
- PE-390 Glucocorticoid-induced Vascular Endothelial Dysfunction and Hypertension are Ameliorated by Pitavastatin, an HMG-CoA Reductase Inhibitor, through Increased Nitric Oxide Production(Cardiovascular pharmacology, basic/clinical-4, The 71st Annual Scien
- OE-211 A Novel eNOS-independent Action of an HMG-CoA Reductase Inhibitor against Angiotensin II-induced Cardiovascular Remodeling(Cardiovascular pharmacology, basic/clinical-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Intra-Vascular Ultrasound Findings of Diffuse Coronary Atherosclerotic Change in Systemic Lupus Erythematosus With Secondary Antiphospholipid Syndrome
- PE-434 Thrombin Inactivation by Synthetic Thrombin Antagonist Argatroban Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice(Diabetes/Obesity/Metabolic syndrome-4 (H) PE73,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
- OJ-077 Improvement of Cardiac Function in Response to Carvedilol is Accompanied by Increased Adiponectin Levels in Patients with Chronic Heart Failure(Heart failure, clinical-3 (M) OJ13,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific M
- OE-138 Plasma Heparin Cofactor II Activity is Inversely Associated with Prevalence of Peripheral Arterial Disease in Elderly individuals(Peripheral circulation-1 (H) OE23,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Ja
- Prompt Decrease of BNP in Early Phase can be a Novel Predictor for Future Effectiveness of Carvedilol in CHF Patients(Heart Failure, Clinical 6 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Pitavastatin Inhibits TNF-α-induced NF-κB Transcriptional Activation through BMK1/ERK5 Activation in Vascular Endothelial Cells(Endothelium/NO 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Angiotensin II Antagonist Valsartan Ameliorates Nitric Oxide Bioavailability Accompanied with the Reduction of Blood Pressure and Pulse Pressure in Hypertensives(Hypertension, Clinical 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation
- Downregulation of Mitochondrial Transcription Factors Play an Important Role in Cardiac Transition From Hypertensive Left Ventricular Hypertrophy to Heart Failure(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation S
- PE-564 Dehydroepiandrosterone Sulfate is an Antivascular Remodeling Factor(PE095,Atherosclerosis (Clinical/Pathophysiology) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
- DPE-065 A Combination of Erythropoietin Administration with Autologous Blood Donation for Therapeutic Angiogenesis(DPE11,Kidney/Renal Circulation/CKD (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Socie
- FRS-005 Heparin Cofactor II-deficient Mice Exert Exacerbation of Angiotensin II-induced Cardiac Remodeling through Enhancement of NADPH oxidase-TGF-β1 Pathway(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73r
- PE-071 A Caution against BNP-guided Treatment for Heart Failure with Atrial Fibrillation(PE012,Heart Failure (Treatment) 1 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-322 Impact of Acute Changes in Serum Insulin-like Growth Factor-1 on Prognosis of Acute Myocardial Infarction(Acute myocardial infarction, clinical(pathophysiology)(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese
- PJ-308 Plasma Heparin Cofactor II Activity is Associated with Plaque Vulnerability in Patients with Stable Angina Pectoris(Atherosclerosis, clinical-10, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-295 PPARα activators suppress PDGF-BB in human megakaryotic tumor cell lines(Atherosclerosis, Basic 3 (IHD) : PJ50)(Poster Session (Japanese))
- PE-047 Aspirin Ameliorates Impaired Production of Endothelial Nitric Oxide in Glucocorticoid Excess(Endothelium/NO 1 (H) : PE8)(Poster Session (English))
- OJ-416 Aspirin and Pitavastatin Increase Expression of Aminopeptidase N/CD13 through the Activation of Akt(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese))
- Antisense Oligonucleotide against Mitochondrial Transcription Factor a (mtTFA) Can Attenuate the Neointimal Formation in a Rat Balloon Injury Model
- Pitavastatin (NK-104) Exerts Vasculo-Protective Action by Upregulation of Endothelial Aminopeptidase N (APN/CD13) Expression
- Apo(a) stimulates the dedifferentiation of vascular smooth muscle cells though the impaired activation of TGF-β in human early atherosclerotic lesions
- Elevated Heparin Cofactor II can Reduce In-stent Restenosis After Percutaneous Coronary Intervention
- Heparin Cofactor II as a Novel Vascular Protective Factor Against Atherosclerosis
- Successful Combination Therapy - Flunarizine, Pentoxifylline, and Cholestyramine - for Spur Cell Anemia
- A Patient with Cyclic Neutropenia Complicated by Severe Persistent Neutropenia Successfully Delivered a Healthy Baby
- No Increased Risk of Thrombosis in Heterozygous Congenital Dysplasminogenemia
- PE-011 Plasma Heparin Cofactor II Activity is a Predictor of Morphological Characteristics of Coronary Arteries Diffuse-Narrowing in Patients with Diabetes Mellitus(Angina pectoris, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circ
- OJ-059 Plasma Heparin Cofactor II Activity Predicts Cardio-and Cerebrovascular Events in Patients with Coronary Heart Disease(Preventive medicine/Epidemiology/Education-2 (H) OJ10,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting
- High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension
- Heparin Cofactor 2 Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals
- PJ-297 Thyroid hormone may protect the development of atherosclerosis by elevating the activity of plasma heparin cofactor II.(Atherosclerosis, Basic 3 (IHD) : PJ50)(Poster Session (Japanese))
- PJ-812 Angiotensin II-induced Cardiac Remodeling is Exacerbated with Increased Oxidative Stress in Heparin Cofactor II-deficient Mice(Cardiovascular pharmacology, basic / clinical(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the J
- PE-498 1 α 25 dihydroxyvitamin D_3 is a protective factor against vascular remodeling and glucose tolerance in elderly individuals(Atherosclerosis, clinical(08)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation So
- OJ-074 Plasma Heparin Cofactor II Activity is Inversely Associated with Left Atrial Size in Elderly Individuals(Cardiac function, basic/clinical(02)(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)